Skip to main content
. 2004 Oct;88(10):1338–1342. doi: 10.1136/bjo.2003.039388

Figure 2.

Figure 2

 Survival of corneal allografts in recipients with prevascularised graft bed and treated with mAb. The recipients were untreated (11 mice) or were treated with mAb anti-CD4 (12 mice), anti-CD8 (six mice), or anti-T cells (seven mice).